Health Condition 1: J45- Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patient having clinical sign and symptoms of bronchial asthma. 2.pre diagnosed cases of bronchial asthma 3.patient from 17-75 year of age. 4.patient of both sexes 5.patients on conventional treatment for bronchial asthma 6. patient giving informed consent
Exclusion criteria
Exclusion criteria: 1.patient suffering from severe persistent asthma2. 2.self reported immunocompromised cases 3.patient with serious illness or other uncontrolled life threatening condition 4.dagnosed cases of psychiatric illness 5. pregnant women and lactating mother 6.substance abuse/dependance 7. patient who are not willing to be a part of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.TO EVALUATE WHICH IS MORE EFFECTIVE i.e. INDIVIDUALISED HOMOEOPATHIC MEDICINE OR ARALIA RACEMOSA MOTHER TINCTURE IN MANAGEMENT OF BRONCHIAL ASTHMA 2. TO ASSESS THE IMPROVEMENT OF PATIENTS IN TERMS OF FREQUENCY OF ATTACK AND SEVERITY OF SYMPTOMS OF ASTHMA.Timepoint: INTIALLY AT BASE LINE AND THEN EVERY MONTH UPTO 1 YEAR . | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. TO ASSESS THE IMPROVEMENT IN SYMPTOMATOLOGY USING ACT SCORE 2. TO ASSESS THE QUALITY OF LIFE BY APPLYING AQLQ.Timepoint: INTIALLY AT BASE LINE AND THEN EVERY MONTH UPTO 1 YEAR | — |
Countries
India
Contacts
NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL